9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Estimated reading time: < 1 min

Condition: Breast Cancer

Estimated Enrollment: 40

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Clinical response (patients with evaluable disease),  Duration of response (patients with evaluable disease),  Survival (patients with evaluable disease), Time to recurrence (patients without evaluable disease)

Interventions: allogeneic tumor cell vaccine, autologous tumor cell vaccine

Phase:

Study Type: Interventional

Study Design: Primary Purpose: Treatment, , ,

Primary Completion Date: December 2007

Completion Date: June 2009

Last  Posted Date: July 10, 2013

Location: St. Vincent Medical Center – Los Angeles, Los Angeles, California, United States

Website Link: https://ClinicalTrials.gov/show/NCT00002475

Was this article helpful?
Dislike 0